Skip to main content

Advertisement

Articles

Page 3 of 8

  1. The objective of this work is to estimate the financial impact of increasing the monitoring period for breast cancer, which is financed by the Sistema de Protección Social en Salud (SPSS—Social Protection Syst...

    Authors: Román Rodríguez-Aguilar, José Antonio Marmolejo-Saucedo and Sonia Tavera-Martínez

    Citation: Cost Effectiveness and Resource Allocation 2018 16:9

    Content type: Research

    Published on:

  2. High pharmaceutical expenditure is one of the main concerns for policymakers worldwide. In Colombia, a middle-income country, outpatient prescription represents over 10% of total health expenditure in the mand...

    Authors: Sergio I. Prada, Victoria E. Soto, Tatiana S. Andia, Claudia P. Vaca, Álvaro A. Morales, Sergio R. Márquez and Alejandro Gaviria

    Citation: Cost Effectiveness and Resource Allocation 2018 16:8

    Content type: Research

    Published on:

  3. Many economic evaluations ignore economies of scale in their cost estimation, which means that cost parameters are assumed to have a linear relationship with the level of production. Economies of scale is the ...

    Authors: Thanthima Suwanthawornkul, Naiyana Praditsitthikorn, Wantanee Kulpeng, Manuel Alexander Haasis, Anna Melissa Guerrero and Yot Teerawattananon

    Citation: Cost Effectiveness and Resource Allocation 2018 16:7

    Content type: Methodology

    Published on:

  4. In Korea, hepatitis B virus (HBV) infection accounts for approximately 65–75% of HBV-related diseases, such as chronic hepatitis and liver cancer, and mother-to-child transmission is presumed to be a major sou...

    Authors: Donghoon Lee, Hyun-Young Shin and Sang Min Park

    Citation: Cost Effectiveness and Resource Allocation 2018 16:6

    Content type: Research

    Published on:

  5. All health care systems in the world struggle with rising costs for drugs. We sought to explore factors impacting on prescribing costs in a nationwide database of ambulatory care in Germany. Factors identified...

    Authors: O. Hirsch, M. Schulz, M. Erhart and N. Donner-Banzhoff

    Citation: Cost Effectiveness and Resource Allocation 2018 16:5

    Content type: Research

    Published on:

  6. Use of malaria rapid diagnostic test (mRDT) enhances patient management and reduces costs associated with the inappropriate use of antimalarials. Despite its proven clinical effectiveness, mRDT is not readily ...

    Authors: Theresa Tawiah, Keziah Malam, Anthony Kwarteng, Constance Bart-Plange, Lawrence Febir, Vivian Aubyn, Konrad Obermann, Seth Owusu-Agyei and Kwaku Poku Asante

    Citation: Cost Effectiveness and Resource Allocation 2018 16:4

    Content type: Research

    Published on:

  7. A significant minority of asthma patients remain uncontrolled despite the use of inhaled corticosteroids (ICS) and long-acting beta-agonists (LABA). A number of add-on therapies, including monoclonal antibodie...

    Authors: Zafar Zafari, Mohsen Sadatsafavi and J. Mark FitzGerald

    Citation: Cost Effectiveness and Resource Allocation 2018 16:3

    Content type: Research

    Published on:

  8. Due to its epidemiological relevance, several studies have been performed to assess the cost-effectiveness of diagnostic tests and treatments in colorectal cancer (CRC) patients.

    Authors: Annamaria Guglielmo, Nicoletta Staropoli, Monica Giancotti and Marianna Mauro

    Citation: Cost Effectiveness and Resource Allocation 2018 16:2

    Content type: Review

    Published on:

  9. The overuse of antibiotics has been identified as a major challenge in regard to the rational prescription of medicines in low and middle income countries. Extensive studies on the effectiveness of persuasive ...

    Authors: Yuqing Tang, Chaojie Liu, Zinan Zhang and Xinping Zhang

    Citation: Cost Effectiveness and Resource Allocation 2018 16:1

    Content type: Research

    Published on:

  10. To date no one has examined the quality of life and direct costs of care in treating early stage breast cancer with adjunct intraoperative radiation therapy (IORT) versus external beam radiation therapy (EBRT)...

    Authors: Rakesh Patel, Olga Ivanov and Jeff Voigt

    Citation: Cost Effectiveness and Resource Allocation 2017 15:22

    Content type: Research

    Published on:

  11. Estimating health care costs, either in the context of understanding resource utilization in the implementation of a health plan, or in the context of economic evaluation, has become a common activity of healt...

    Authors: Melanie Y. Bertram, Karin Stenberg, Callum Brindley, Jina Li, Juliana Serje, Rory Watts and Tessa Tan-Torres Edejer

    Citation: Cost Effectiveness and Resource Allocation 2017 15:21

    Content type: Methodology

    Published on:

  12. Anti-tumor necrosis factor (anti-TNF) agents are an effective, but costly, treatment for spondyloarthritis (SpA). Worldwide, multiple sets of access criteria aim to restrict anti-TNF therapy to patients with s...

    Authors: Stephanie Harvard, Daphne Guh, Nick Bansback, Pascal Richette, Alain Saraux, Bruno Fautrel and Aslam Anis

    Citation: Cost Effectiveness and Resource Allocation 2017 15:20

    Content type: Research

    Published on:

  13. This study was designed to assess the cost-effectiveness of vildagliptin versus glimepiride as add-on to metformin in the management of type 2 diabetes mellitus (T2DM) patients in the Greek healthcare setting.

    Authors: Hara Kousoulakou, Magdalini Hatzikou, Varvara Baroutsou and John Yfantopoulos

    Citation: Cost Effectiveness and Resource Allocation 2017 15:19

    Content type: Research

    Published on:

  14. The aim of this study was to assess the cost-effectiveness of human papillomavirus (HPV) vaccination in addition to the current cervical cancer screening programme in Germany using a dynamic transmission model.

    Authors: Oliver Damm, Johannes Horn, Rafael T. Mikolajczyk, Mirjam E. E. Kretzschmar, Andreas M. Kaufmann, Yvonne Deleré, Bernhard Ultsch, Ole Wichmann, Alexander Krämer and Wolfgang Greiner

    Citation: Cost Effectiveness and Resource Allocation 2017 15:18

    Content type: Research

    Published on:

  15. Currently, two pediatric pneumococcal conjugate vaccines are available in the private market of Malaysia—13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide and non-typeable Haemophil...

    Authors: Xiao Jun Wang, Ashwini Saha and Xu-Hao Zhang

    Citation: Cost Effectiveness and Resource Allocation 2017 15:17

    Content type: Research

    Published on:

  16. In countries such as Cyprus the financial crisis and the recession have severely affected the funding and priority setting of the health care system. There is evidence highlighting the importance of population...

    Authors: Antonis Farmakas, Mamas Theodorou, Petros Galanis, Georgios Karayiannis, Stefanos Ghobrial, Nikos Polyzos, Evridiki Papastavrou, Eirini Agapidaki and Kyriakos Souliotis

    Citation: Cost Effectiveness and Resource Allocation 2017 15:16

    Content type: Research

    Published on:

  17. As treatments for chronic hepatitis C are moving away from interferon-containing regimens, the most appropriate allocation of resources to higher cost, interferon-free, direct-acting antiviral (DAA) regimens n...

    Authors: Phil McEwan, Samantha Webster, Thomas Ward, Michael Brenner, Anupama Kalsekar and Yong Yuan

    Citation: Cost Effectiveness and Resource Allocation 2017 15:15

    Content type: Research

    Published on:

  18. In 2013, 78% of malaria deaths occurred in children aged 5 years and below, in sub-Saharan Africa. Treatment of severe malaria requires a health facility with inpatient care. However, in most sub-Sahara Africa...

    Authors: Vivian Rakuomi, Faith Okalebo, Stanley Ndwigah and Levi Mbugua

    Citation: Cost Effectiveness and Resource Allocation 2017 15:14

    Content type: Research

    Published on:

  19. This study evaluated the potential cost-effectiveness of cervical cancer screening in HIV treatment clinics in Nairobi, Kenya.

    Authors: Marita R. Zimmermann, Elisabeth Vodicka, Joseph B. Babigumira, Timothy Okech, Nelly Mugo, Samah Sakr, Louis P. Garrison and Michael H. Chung

    Citation: Cost Effectiveness and Resource Allocation 2017 15:13

    Content type: Research

    Published on:

  20. Innovations that improve the affordability, accessibility, or effectiveness of health care played a major role in the Millennium Development Goal achievements and will be critical for reaching the ambitious ne...

    Authors: Tara Herrick, Claudia Harner-Jay, Craig Shaffer, Greg Zwisler, Peder Digre and Amie Batson

    Citation: Cost Effectiveness and Resource Allocation 2017 15:12

    Content type: Research

    Published on:

  21. In Italy HPV vaccination with the quadrivalent vaccine (Gardasil®) is offered actively and free of charge to girls aged 12 since 2007. A nine-valent vaccine (Gardasil 9®) received the European market authorizatio...

    Authors: Francesco Saverio Mennini, Paolo Bonanni, Florence Bianic, Chiara de Waure, Gianluca Baio, Giacomo Plazzotta, Mathieu Uhart, Alessandro Rinaldi and Nathalie Largeron

    Citation: Cost Effectiveness and Resource Allocation 2017 15:11

    Content type: Research

    Published on:

  22. Malaria continues to be a public health problem despite past and on-going control efforts. For sustenance of control efforts to achieve the malaria elimination goal, it is important that the most cost-effectiv...

    Authors: Resign Gunda and Moses John Chimbari

    Citation: Cost Effectiveness and Resource Allocation 2017 15:10

    Content type: Review

    Published on:

  23. This study evaluates the cost-effectiveness of the DAZT program for scaling up treatment of acute child diarrhea in Gujarat India using a net-benefit regression framework.

    Authors: Samuel D. Shillcutt, Amnesty E. LeFevre, Christa L. Fischer-Walker, Sunita Taneja, Robert E. Black and Sarmila Mazumder

    Citation: Cost Effectiveness and Resource Allocation 2017 15:9

    Content type: Research

    Published on:

  24. Ofatumumab (Arzerra®, Novartis) is a treatment for chronic lymphocytic leukemia refractory to fludarabine and alemtuzumab [double refractory (DR-CLL)]. Ofatumumab was licensed on the basis of an uncontrolled Phas...

    Authors: Anthony J. Hatswell, Gwilym J. Thompson, Penny A. Maroudas, Oleg Sofrygin and Thomas E. Delea

    Citation: Cost Effectiveness and Resource Allocation 2017 15:8

    Content type: Methodology

    Published on:

  25. This study aims to summarise and describe the evolution of published economic evaluations of vaccines in Canada, thereby outlining the current state of this expanding and meaningful research.

    Authors: Ellen R. S. Rafferty, Heather L. Gagnon, Marwa Farag and Cheryl L. Waldner

    Citation: Cost Effectiveness and Resource Allocation 2017 15:7

    Content type: Review

    Published on:

  26. This study is an initial effort to examine the dynamics of efficiency and productivity in Greek public hospitals during the first phase of the crisis 2009–2012. Data were collected by the Ministry of Health af...

    Authors: P. Xenos, J. Yfantopoulos, M. Nektarios, N. Polyzos, P. Tinios and A. Constantopoulos

    Citation: Cost Effectiveness and Resource Allocation 2017 15:6

    Content type: Research

    Published on:

  27. Mobile and wireless technology for health (mHealth) has the potential to improve health outcomes by addressing critical health systems constraints that impede coverage, utilization, and effectiveness of health...

    Authors: Amnesty E. LeFevre, Samuel D. Shillcutt, Sean Broomhead, Alain B. Labrique and Tom Jones

    Citation: Cost Effectiveness and Resource Allocation 2017 15:5

    Content type: Methodology

    Published on:

  28. In resource-limited settings with a high prevalence of human immunodeficiency virus (HIV) infection such as Zambia, decentralization of HIV/acquired immunodeficiency syndrome (HIV/AIDS) treatment and care with...

    Authors: Shinsuke Miyano, Gardner Syakantu, Kenichi Komada, Hiroyoshi Endo and Tomohiko Sugishita

    Citation: Cost Effectiveness and Resource Allocation 2017 15:4

    Content type: Research

    Published on:

  29. Health care systems around the world have started to develop pharmacists prescribing for minor ailments (PPMA) programs. These programs aim to improve the efficiency of care, reduce physician visits, and incre...

    Authors: Ellen Rafferty, Mohsen Yaghoubi, Jeff Taylor and Marwa Farag

    Citation: Cost Effectiveness and Resource Allocation 2017 15:3

    Content type: Research

    Published on:

  30. Neonatal mortality remains unacceptably high in many low and middle-income countries, including India. A community mobilisation intervention using participatory learning and action with women’s groups facilita...

    Authors: Rajesh Kumar Sinha, Hassan Haghparast-Bidgoli, Prasanta Kishore Tripathy, Nirmala Nair, Rajkumar Gope, Shibanand Rath and Audrey Prost

    Citation: Cost Effectiveness and Resource Allocation 2017 15:2

    Content type: Research

    Published on:

  31. Economic evidence is influential in health technology assessment world-wide. Clinical Practice Guidelines (CPG) can enable economists to include economic information on health care provision. Application of ec...

    Authors: Kathryn M. Antioch, Michael F. Drummond, Louis W. Niessen and Hindrik Vondeling

    Citation: Cost Effectiveness and Resource Allocation 2017 15:1

    Content type: Review

    Published on:

  32. In Nepal, pre-eclampsia/eclampsia (PE/E) causes an estimated 21% of maternal deaths annually and contributes to adverse neonatal birth outcomes. Calcium supplementation has been shown to reduce the risk of PE/...

    Authors: Isabelle Feldhaus, Amnesty E. LeFevre, Chandra Rai, Jona Bhattarai, Deirdre Russo, Barbara Rawlins, Pushpa Chaudhary and Kusum Thapa

    Citation: Cost Effectiveness and Resource Allocation 2016 14:13

    Content type: Research

    Published on:

  33. Long-term care for older people is provided in both residential and non-residential settings, with residential settings tending to cater for individuals with higher care needs. Evidence relating to the costs a...

    Authors: Tiffany Easton, Rachel Milte, Maria Crotty and Julie Ratcliffe

    Citation: Cost Effectiveness and Resource Allocation 2016 14:12

    Content type: Review

    Published on:

  34. Zoledronic acid and denosumab were funded by the Australian government for the management of osteoporosis at an equivalent price to alendronate. The price of alendronate has declined by around 65 %, but the pr...

    Authors: Jonathan Karnon, Ainul Shakirah Shafie, Nneka Orji and Sofoora Kawsar Usman

    Citation: Cost Effectiveness and Resource Allocation 2016 14:11

    Content type: Research

    Published on:

  35. The coverage of prevention and treatment strategies for ischemic heart disease and stroke is very low in Ethiopia. In view of Ethiopia’s meager healthcare budget, it is important to identify the most cost-effe...

    Authors: Mieraf Taddesse Tolla, Ole Frithjof Norheim, Solomon Tessema Memirie, Senbeta Guteta Abdisa, Awel Ababulgu, Degu Jerene, Melanie Bertram, Kirsten Strand, Stéphane Verguet and Kjell Arne Johansson

    Citation: Cost Effectiveness and Resource Allocation 2016 14:10

    Content type: Research

    Published on:

  37. Human papilloma virus (HPV) vaccination in Nigeria will require substantial financing due to high cost of HPV vaccine and inexistence of structures to support adolescent vaccination. Alternative sources are ne...

    Authors: Ifeoma Blessing Umeh, Sunday Odunke Nduka and Obinna Ikechukwu Ekwunife

    Citation: Cost Effectiveness and Resource Allocation 2016 14:8

    Content type: Research

    Published on:

  38. To conduct a cost-utility analysis of ranibizumab versus aflibercept for the treatment of patients with visual impairment due to diabetic macular edema (DME) in the Greek setting.

    Authors: Georgia Kourlaba, John Relakis, Ronan Mahon, Maria Kalogeropoulou, Georgia Pantelopoulou, Olga Kousidou and Nikos Maniadakis

    Citation: Cost Effectiveness and Resource Allocation 2016 14:7

    Content type: Research

    Published on:

  39. The objective of this analysis was to determine the value (incremental cost/increment benefit) of a brain LITT system versus employing current surgical options recommended by NCCN guidelines, specifically open...

    Authors: Jeffrey D. Voigt and Gene Barnett

    Citation: Cost Effectiveness and Resource Allocation 2016 14:6

    Content type: Research

    Published on:

  40. The editors of Cost Effectiveness and Resource Allocation would like to thank all our reviewers who have contributed to the journal in volume 13 (2015).

    Authors: Joan Rovira

    Citation: Cost Effectiveness and Resource Allocation 2016 14:5

    Content type: Reviewer acknowledgement

    Published on:

  41. Streptococcus pneumoniae is a common cause of child death. However, the economic burden of pneumococcal disease in low-income countries is poorly described. We aimed to estimate from a...

    Authors: Effua Usuf, Grant Mackenzie, Sana Sambou, Deborah Atherly and Chutima Suraratdecha

    Citation: Cost Effectiveness and Resource Allocation 2016 14:4

    Content type: Research

    Published on:

  43. Newborn mortality, comprising a third of all under-5 deaths, has hardly changed in low and middle income countries (LMICs) including South Africa over the past decade. To attain the MDG 4 target, greater empha...

    Authors: Mandy Maredza, Lumbwe Chola and Karen Hofman

    Citation: Cost Effectiveness and Resource Allocation 2016 14:2

    Content type: Review

    Published on:

  45. Despite improvements in a number of health outcome indicators partly due to the National Health Insurance Scheme (NHIS), Ghana is unlikely to attain all its health-related millennium development goals before t...

    Authors: Robert Kaba Alhassan, Edward Nketiah-Amponsah, James Akazili, Nicole Spieker, Daniel Kojo Arhinful and Tobias F Rinke de Wit

    Citation: Cost Effectiveness and Resource Allocation 2015 13:23

    Content type: Research

    Published on:

  46. The cost-effectiveness of umeclidinium bromide-vilanterol (UMEC/VI) versus tiotropium monotherapy in the UK was assessed using a UMEC/VI treatment-specific economic model based on a chronic obstructive pulmona...

    Authors: Yogesh Suresh Punekar, Graeme Roberts, Afisi Ismaila and Martin O’Leary

    Citation: Cost Effectiveness and Resource Allocation 2015 13:22

    Content type: Research

    Published on:

  47. All international guidelines suggested that Tenofovir and Entecavir are the primary drugs at the first line therapy for the treatment of chronic hepatitis B (CHB). However, in Turkey these medications reimburs...

    Authors: Guvenc Kockaya, Akin Kose, Fatma Betul Yenilmez, Oktay Ozdemir and Ece Kucuksayrac

    Citation: Cost Effectiveness and Resource Allocation 2015 13:21

    Content type: Research

    Published on:

  48. The rapid and continuous growth of health care cost aggravates the frequently low priority and less attention given in financing laboratory services. The poorest countries have the highest out-of-pocket spend...

    Authors: Kasaw Adane, Zenegnaw Abiy and Kassu Desta

    Citation: Cost Effectiveness and Resource Allocation 2015 13:20

    Content type: Research

    Published on:

  49. In the Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST elevation myocardial infarction (FAMOUS) clinical trial, FFR was shown to significantly reduce coro...

    Authors: Julian Nam, Andrew Briggs, Jamie Layland, Keith G. Oldroyd, Nick Curzen, Arvind Sood, Kanarath Balachandran, Raj Das, Shahid Junejo, Hany Eteiba, Mark C. Petrie, Mitchell Lindsay, Stuart Watkins, Simon Corbett, Brian O’Rourke, Anna O’Donnell…

    Citation: Cost Effectiveness and Resource Allocation 2015 13:19

    Content type: Research

    Published on:

  50. Sequential treatment of ankylosing spondylitis (AS) that includes tumour necrosis factor-α antagonists (anti-TNF agents) has been applied in most of the Western countries. Existing cost-effectiveness (CE) mode...

    Authors: An Tran-Duy, Annelies Boonen, Mart A. F. J. van de Laar and Johan L. Severens

    Citation: Cost Effectiveness and Resource Allocation 2015 13:18

    Content type: Research

    Published on:

Submit manuscript

Annual Journal Metrics

Advertisement

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us